Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 209501
Company: UPJOHN
Company: UPJOHN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LYRICA CR | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | No |
LYRICA CR | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | No |
LYRICA CR | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/11/2017 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209501s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209501Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209501Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
12/13/2023 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209501s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021446Orig1s041,%20022488Orig1s018,%20209501Orig1s005Correctedltr.pdf | |
04/03/2020 | SUPPL-3 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209501s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/209501Orig1s003ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/13/2023 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209501s005lbl.pdf | |
04/03/2020 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209501s003lbl.pdf | |
10/11/2017 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209501s000lbl.pdf |
LYRICA CR
TABLET, EXTENDED RELEASE;ORAL; 82.5MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
LYRICA CR | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 209501 | UPJOHN |
PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 211593 | ALVOGEN |
PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 214496 | EPIC PHARMA LLC |
PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 213226 | MSN |
PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 215249 | RUBICON |
PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 211889 | SUN PHARM |
TABLET, EXTENDED RELEASE;ORAL; 165MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
LYRICA CR | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 209501 | UPJOHN |
PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 211593 | ALVOGEN |
PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 213313 | APOTEX |
PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 214496 | EPIC PHARMA LLC |
PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 213226 | MSN |
PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 215249 | RUBICON |
PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 211889 | SUN PHARM |
TABLET, EXTENDED RELEASE;ORAL; 330MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
LYRICA CR | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 209501 | UPJOHN |
PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 211593 | ALVOGEN |
PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 213313 | APOTEX |
PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 214496 | EPIC PHARMA LLC |
PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 213226 | MSN |
PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 215249 | RUBICON |
PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 211889 | SUN PHARM |